Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Class A Common Stock, par value $0.01
Shares outstanding
313,041,907
Total 13F shares
99,933,342
Share change
-1,638,066
Total reported value
$511,565,477
Put/Call ratio
118%
Price per share
$5.12
Number of holders
153
Value change
-$13,076,955
Number of buys
77
Number of sells
73

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Fosun International Ltd
13F
Company
6.9%
21,521,301
$144,839,000 31 Mar 2021
13F
TPG Group Holdings (SBS) Advisors, Inc.
13F
Company
5.2%
16,213,367
$109,116,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
3.5%
11,104,911
$74,736,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
2.4%
7,664,792
$51,583,000 31 Mar 2021
13F
Eversept Partners, LP
13F
Company
1.5%
4,755,480
$32,004,380 31 Mar 2021
13F
Neuberger Berman Group LLC
13F
Company
1.1%
3,434,266
$22,959,000 31 Mar 2021
13F
Point72 Asset Management, L.P.
13F
Company
0.94%
2,931,900
$19,732,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
0.78%
2,435,002
$16,388,000 31 Mar 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.74%
2,309,907
$15,546,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.58%
1,821,717
$12,260,000 31 Mar 2021
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.57%
1,787,662
$12,031,000 31 Mar 2021
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.53%
1,663,052
$11,192,000 31 Mar 2021
13F
MARSHALL WACE, LLP
13F
Company
0.49%
1,532,897
$10,317,000 31 Mar 2021
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.41%
1,299,114
$8,743,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.41%
1,275,306
$8,583,000 31 Mar 2021
13F
LSV ASSET MANAGEMENT
13F
Company
0.4%
1,263,600
$8,504,000 31 Mar 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.29%
917,707
$6,176,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.28%
885,914
$5,963,000 31 Mar 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.27%
833,782
$5,610,000 31 Mar 2021
13F
NORGES BANK
13F
Company
0.26%
807,906
$5,437,000 31 Mar 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.24%
739,768
$4,979,000 31 Mar 2021
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.23%
731,528
$4,923,000 31 Mar 2021
13F
JUPITER ASSET MANAGEMENT LTD
13F
Company
0.22%
696,117
$4,685,000 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
0.2%
639,543
$4,304,000 31 Mar 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.2%
620,515
$4,176,000 31 Mar 2021
13F
Hillsdale Investment Management Inc.
13F
Company
0.2%
611,200
$4,113,000 31 Mar 2021
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.16%
511,752
$3,444,000 31 Mar 2021
13F
Marshall Wace North America L.P.
13F
Company
0.15%
484,778
$3,263,000 31 Mar 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.14%
448,660
$3,019,000 31 Mar 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.14%
424,102
$2,854,000 31 Mar 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.13%
416,904
$2,805,000 31 Mar 2021
13F
Global IMC LLC
13F
Company
0.12%
365,719
$2,461,000 31 Mar 2021
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.11%
333,498
$2,244,000 31 Mar 2021
13F
Cubist Systematic Strategies, LLC
13F
Company
0.09%
290,296
$1,954,000 31 Mar 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.09%
268,749
$1,809,000 31 Mar 2021
13F
Informed Momentum Co LLC
13F
Company
0.08%
259,873
$1,749,000 31 Mar 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.08%
258,132
$1,737,000 31 Mar 2021
13F
Assenagon Asset Management S.A.
13F
Company
0.08%
244,400
$1,645,000 31 Mar 2021
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.08%
236,400
$1,591,000 31 Mar 2021
13F
M&G INVESTMENT MANAGEMENT LTD
13F
Company
0.07%
221,447
$1,550,000 31 Mar 2021
13F
Jackson Creek Investment Advisors LLC
13F
Company
0.07%
221,043
$1,488,000 31 Mar 2021
13F
Invesco Ltd.
13F
Company
0.07%
218,948
$1,473,000 31 Mar 2021
13F
Swiss National Bank
13F
Company
0.07%
217,000
$1,460,000 31 Mar 2021
13F
HUSSMAN STRATEGIC ADVISORS, INC.
13F
Company
0.06%
180,000
$1,211,000 31 Mar 2021
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.06%
175,861
$1,184,000 31 Mar 2021
13F
Brandywine Global Investment Management, LLC
13F
Company
0.06%
175,813
$1,183,000 31 Mar 2021
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.05%
170,052
$1,144,000 31 Mar 2021
13F
Quadrature Capital Ltd
13F
Company
0.05%
160,801
$1,082,000 31 Mar 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
154,250
$1,038,000 31 Mar 2021
13F
MORGAN STANLEY
13F
Company
0.05%
154,324
$1,037,000 31 Mar 2021
13F

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2021

As of 30 Jun 2021, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,933,342 shares. The largest 10 holders included Fosun International Ltd, TPG Group Holdings (SBS) Advisors, Inc., VANGUARD GROUP INC, BlackRock Inc., Eversept Partners, LP, Neuberger Berman Group LLC, STATE STREET CORP, Nuveen Asset Management, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and VICTORY CAPITAL MANAGEMENT INC. This page lists 153 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
155
Q2 2021 holders
153
Holder diff
-2
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.